首页 正文

Phase I clinical trials for cardiovascular diseases in Europe: analysis of trends, distribution, and regulatory context

{{output}}
Introduction: Cardiovascular diseases and their major metabolic risk factors remain the leading contributors to morbidity and mortality in Europe. Despite the growing burden of cardiometabolic conditions and the critical role of ... ...